Pfizer, BioNTech begin testing COVID-19 vaccine in children under 12
IslamNews – The BioNTech-Pfizer coronavirus vaccine is now being tested on young children under-12, with efficacy data expected later this year. The vaccine makers hope the shot can be administered to kids by 2022.
US pharmaceutical giant Pfizer announced Thursday its joint vaccine with German company BioNTech SE would begin trials on children under 12 years old. The vaccine is currently authorized by US regulators for ages 16 and older.
“Together with our partner BioNTech, we have announced a global study to further evaluate our COVID-19 vaccine in healthy children ages 6 months to 11 years,” Pfizer CEO and Chairman Albert Bourla said in a tweet. “We are proud to start this much needed study for children and families awaiting a possible vaccine option.”
Pfizer is the latest company to test its vaccine on young children, after Moderna announced trials on the same age group earlier this month. Johnson & Johnson also plans to test its vaccine on children and infants.